Hypertensive Treatment Pattern Survey for Type II Diabetes Mellitus Patients With Complication and Hypertension - Full Text View

Hypertensive Treatment Pattern Survey for Type II Diabetes Mellitus Patients With Complication and Hypertension (CRYSTAL-CO)

This study is ongoing, but not recruiting participants.

First Received: October 9, 2008 Last Updated: November 26, 2008 History of Changes

Sponsored by:	AstraZeneca
Information provided by:	AstraZeneca
ClinicalTrials.gov Identifier:	NCT00771069

Purpose

This study will address the treatment rate and control rate of hypertension, treatment pattern and factors to affect blood pressure control by examining (retrospective) medical records of Type II DM patients with DM related complication and hypertension, among outpatients coming to the Endocrinology Department in 20 general hospital settings nationwide.

Condition
Hypertension

MedlinePlus related topics: Diabetes High Blood Pressure

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Retrospective
Official Title:	A Retrospective, Multi Centre, Non-Interventional, Observational Study to Investigate Treatment Pattern of Blood Pressure in the Type II Diabetes Mellitus Patients With DM Related Complication and Hypertension.

Further study details as provided by AstraZeneca:

Primary Outcome Measures:

Attainment rate to the target blood pressure. [ Time Frame: After collecting all Patient Record Form. ]

Secondary Outcome Measures:

Attainment to the target blood pressure will be investigated according to DM related complications. [ Time Frame: After collecting all Patient Record Form. ]
Change in the DBP/SBP value will be investigated according to the DM Complication [ Time Frame: After collecting all Patient Record Form. ]
Treatment pattern and factors that affect BP control [ Time Frame: After collecting all Patient Record Form. ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	2000
Study Start Date:	October 2008
Estimated Study Completion Date:	May 2009

Groups/Cohorts
1 Type II Diabetes Mellitus patients with Complication and Hypertension

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Type II Diabetes Mellitus patients with Complication and Hypertension

Criteria

Inclusion Criteria:

After diagnosed type II DM, patients received treatment for a least 3 years
Type II DM patients with hypertension and its complication.
Visited out-patients to care center after 1 Jan. 2008

Exclusion Criteria:

Secondary hypertension patients
Patients not receiving hypertension medication
Patients stopping BP medication, by physician's order
Patients currently enrolled in other clinical studies

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00771069

Locations

Korea, Republic of
Research Site
Busan, Korea, Republic of
Research Site
Deagu, Korea, Republic of
Research Site
Deajeon, Korea, Republic of
Research Site
Seoul, Korea, Republic of
Research Site
Kwangju, Korea, Republic of
Research Site
Incheon, Korea, Republic of
Korea, Republic of, Gyeonggi
Research Site
Bucheon, Gyeonggi, Korea, Republic of
Research Site
Goyang, Gyeonggi, Korea, Republic of
Research Site
Guri, Gyeonggi, Korea, Republic of
Research Site
Sungnam, Gyeonggi, Korea, Republic of
Research Site
Suwon, Gyeonggi, Korea, Republic of
Korea, Republic of, Kangwon
Research Site
Wonju, Kangwon, Korea, Republic of
Korea, Republic of, Keollabuk
Research Site
Jeonju, Keollabuk, Korea, Republic of

Sponsors and Collaborators

AstraZeneca

Investigators

Study Director:

Joonwoo Bahn

Astrazenca Korea

More Information

No publications provided

Study ID Numbers:	NIS-CKR-DUM-2008/3
Study First Received:	October 9, 2008
Last Updated:	November 26, 2008
ClinicalTrials.gov Identifier:	NCT00771069 History of Changes
Health Authority:	Korea: Food and Drug Administration

Keywords provided by AstraZeneca:

Hypertension
Type II DM
DM related complication

JNC7
2007 ESH-ESC guidelines
survey

Study placed in the following topic categories:

Metabolic Diseases
Diabetes Mellitus, Type 2
Vascular Diseases
Diabetes Mellitus
Endocrine System Diseases

Endocrinopathy
Glucose Metabolism Disorders
Metabolic Disorder
Hypertension

Additional relevant MeSH terms:

Metabolic Diseases
Diabetes Mellitus, Type 2
Vascular Diseases
Diabetes Mellitus

Endocrine System Diseases
Cardiovascular Diseases
Glucose Metabolism Disorders
Hypertension

ClinicalTrials.gov processed this record on May 06, 2009